comparemela.com

Latest Breaking News On - Stefan quenneville - Page 1 : comparemela.com

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his “Buy” rating on Nova Leap Health.

Massachusetts
United-states
Chris-dobbin
Stefan-quenneville
Nova-leap-health-stock
Unitedhealth-group-inc
Amedisys
Echelon-capital-markets
Nova-leap-health
Nova-leap-health-stock-quote
Nova-leap
Unitedhealth-group

NSCI stock is undervalued, Echelon says

Following the release of preliminary fourth quarter results, Echelon analyst Stefan Quenneville remains bullish about Nanalysis Scientific.

Stefan-quenneville
Sean-krakiwsky
Nanalysis-scientific
Nanalysis-scientific-stock-quote

VPH stock has price target lowered at Echelon

Following the company’s fourth quarter results, Echelon Capital Markets analyst Stefan Quenneville has lowered his price target on Valeo Pharma

Valeo-pharma
Stefan-quenneville
Steve-saviuk
Echelon-capital-markets
Valeo-pharma-stock-quote

Tuesday's analyst upgrades and downgrades - The Globe and Mail

Inside the Market’s roundup of some of today’s key analyst actions

Winnipeg
Manitoba
Canada
Serbia
Texas
United-states
Couche
Poitou-charentes
France
Nevada
Quebec
Cobre

Buy ATE stock for a double, Echelon says

Following the company’s Q2, 2024 interim results, Echelon analyst Stefan Quenneville still thinks there is money to be made on Antibe Therapeutics

Dan-legault
Stefan-quenneville
Echelon-capital-markets
Antibe-therapeutics
Antibe-therapeutics-stock-quote
Speculative-buy

vimarsana © 2020. All Rights Reserved.